Supergen Jumps

Open Text slides; Corinthian Colleges advances; plus more of Wednesday's stocks in the news

Supergen (SUPG ) granted MGI Pharmaceuticals (MGON ) exclusive worldwide rights to develop, manufacture, and distribute Supergen's anti-cancer drug Dacogen. MGI will make a $40 million equity investment in Supergen. First Boston upgraded Supergen to buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.